These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7236312)

  • 1. Studies on the mechanism of resistance of selected murine tumors to L-alanosine.
    Tyagi AK; Cooney DA; Jayaram HN; Swiniarski JK; Johnson RK
    Biochem Pharmacol; 1981 May; 30(9):915-24. PubMed ID: 7236312
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental antitumor activity and toxicity of a new chemotherapeutic agent, BBM 928A.
    Rose WC; Schurig JE; Huftalen JB; Bradner WT
    Cancer Res; 1983 Apr; 43(4):1504-10. PubMed ID: 6831399
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of copper and zinc by the antitumour agent L-alanosine.
    Powis G; Kovach JS
    Biochem Pharmacol; 1981 Apr; 30(7):771-6. PubMed ID: 7247961
    [No Abstract]   [Full Text] [Related]  

  • 4. Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.
    Chiuten DF; Muggia FM; Johnson RK
    Cancer Treat Rep; 1979; 63(11-12):1857-62. PubMed ID: 93512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antitumor activity of macromomycin].
    Kato T; Yamanaka N; Katayama S; Mizutani M; Ota K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1097-101. PubMed ID: 7184442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of bacteriohopane-32-ol against mouse leukemia L1210 and P388 cells in vitro.
    Nagumo A; Takanashi K; Hojo H; Suzuki Y
    Toxicol Lett; 1991 Nov; 58(3):309-13. PubMed ID: 1957326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alanosine toxicity in Novikoff rat hepatoma cells due to inhibition of the conversion of inosine monophosphate to adenosine monophosphate.
    Graff JC; Plagemann PG
    Cancer Res; 1976 Apr; 36(4):1428-40. PubMed ID: 177207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineoplastic and curative antileukemic activity of 1,4-benzoquinone guanylhydrazone thiosemicarbazone and its hydrochloride on in vivo murine models].
    Gutsche W; Schulze W; Jungstand W; Wohlrabe K
    Pharmazie; 1983 Feb; 38(2):105-7. PubMed ID: 6856662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WF-3405, a novel antitumor antibiotic. Taxonomy, isolation, structure elucidation and biological properties.
    Kiyoto S; Murai H; Tsurumi Y; Terano H; Kohsaka M; Takase S; Uchida I; Hashimoto M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1987 Mar; 40(3):290-5. PubMed ID: 3570981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some chemotherapeutic properties of two new antitumor antibiotics, saframycins A and C.
    Arai T; Takahashi K; Ishiguro K; Mikami Y
    Gan; 1980 Dec; 71(6):790-6. PubMed ID: 7274625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic effects of compound 593A (NSC-135758) on mouse leukemias and some transplanted animal tumors.
    Tarnowski GS; Schmid FA; Hutchison DJ; Stock CC
    Cancer Chemother Rep; 1973 Feb; 57(1):21-7. PubMed ID: 4704098
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
    Fujimoto K; Oka T; Morimoto M
    Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.
    Venditti JM; Wesley RA; Plowman J
    Adv Pharmacol Chemother; 1984; 20():1-20. PubMed ID: 6398966
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of the antimetabolite of L-alanosine, L-alanosyl-5-amino-4-imidazolecarboxylic acid ribonucleotide, in tumors and assessment of its inhibition of adenylosuccinate synthetase.
    Tyagi AK; Cooney DA
    Cancer Res; 1980 Dec; 40(12):4390-7. PubMed ID: 7438071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
    Batova A; Diccianni MB; Omura-Minamisawa M; Yu J; Carrera CJ; Bridgeman LJ; Kung FH; Pullen J; Amylon MD; Yu AL
    Cancer Res; 1999 Apr; 59(7):1492-7. PubMed ID: 10197619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of the toxicity of L-alanosine to various organs of the mouse.
    Tyagi AK; Thake DC; McGee E; Cooney DA
    Toxicology; 1981; 21(1):59-69. PubMed ID: 7281196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.
    Mabel JA; Wodinsky I
    Cancer; 1983 Feb; 51(4):600-5. PubMed ID: 6401590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
    Dawson KM
    Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN; Ardalan B; Deas M; Johnson RK
    Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.